MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, ACH made $627,780K in revenue. -$6,468K in net income. Net profit margin of -1.03%.

Income Overview

Revenue
$627,780K
Net Income
-$6,468K
Net Profit Margin
-1.03%
EPS
-$0.08
Unit: Thousand (K) dollars
Revenue Breakdown
    • Diabetes Product
    • Sleep Therapy Product
    • Home Respiratory Therapy Product
    • Others
Revenue Breakdown
    • Commercial Payors
    • Medicare
    • Medicaid

Income Statement
2026-03-31
2025-12-31
Net revenue
627,780 690,508*
Cost of net revenue
349,752 368,183*
Selling, general and administrative expenses
255,226 266,890*
Transaction breakage fee
-20,000*
Acquisition-related charges and intangible amortization
29,229 23,958*
Exit and realignment charges, net
-4,612*
Exit and realignment (income) charges, net
-23,552 -
Total operating costs and expenses
610,655 683,643*
Operating income
17,125 6,865*
Interest expense, net
32,348 26,796*
Transaction financing fees, net
-4,572*
Other expense, net
-1,023 -985*
Loss from continuing operations before income taxes
-16,246 -25,488*
Income tax benefit
-9,778 182*
Loss from continuing operations, net of tax
-6,468 -25,670*
Net revenue
-1,977,414*
Cost of goods sold
-1,781,286*
Gross profit
-196,128*
Distribution, selling, and administrative expenses
-195,697*
Acquisition-related charges and intangible amortization
-3,137*
Exit and realignment charges, net
-18,095*
Goodwill impairment charge
-26,597*
Loss on classification to held for sale
-199,732*
Other operating expense, net
--2,733*
Operating (loss) income
--249,864*
Interest expense, net
--9,000*
Other expense
-351*
Loss from discontinued operations before income taxes
--259,216*
Income tax benefit for discontinued operations
--9,727*
Loss from discontinued operations, net of tax
--249,489*
Net loss
-6,468 -275,160
Basic EPS
-0.08 -3.578
Diluted EPS
-0.08 -3.578
Basic Average Shares
76,432,000 76,897,000
Diluted Average Shares
76,432,000 76,897,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net loss-$6,468K Diabetes Product$185,786K Sleep Therapy Product$166,922K Home RespiratoryTherapy Product$97,179K Product And ServiceOther$57,365K Ostomy$51,336K Wound Care$39,402K Urology$29,790K Loss from continuingoperations, net of tax-$6,468K Income tax benefit-$9,778K Net revenue$627,780K Loss from continuingoperations before income...-$16,246K Operating income$17,125K Total operating costsand expenses$610,655K Exit and realignment(income) charges, net-$23,552K Interest expense, net$32,348K Other expense, net-$1,023K Cost of net revenue$349,752K Selling, general andadministrative expenses$255,226K Acquisition-related charges andintangible amortization$29,229K

ACCENDRA HEALTH INC VA (ACH)

ACCENDRA HEALTH INC VA (ACH)